Pulmonary hypertension in connective tissue diseases

Symposium
Chairs: P. Hassoun (Baltimore, Md, United States of America), M. Humbert (Clamart, France)
Aims: The aims of this symposium will be:
• to understand cellular and molecular changes involved in pulmonary arterial hypertension (PAH) related to connective tissue diseases (CTD);
• to understand cardio-pulmonary interaction in CTD-related PAH;
• to assess novel targeted therapies for this syndrome.
Inflammatory pathways leading to pulmonary arterial hypertension in connective tissue diseases
M. Humbert (Clamart, France)
Slide presentationMultimedia files
Slide presentationMultimedia files
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension
A. Vonk Noordegraaf (Amsterdam, Netherlands)
Slide presentationMultimedia files
Slide presentationMultimedia files
Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension
P. Hassoun (Baltimore, Md, United States of America)
Slide presentationMultimedia files
Slide presentationMultimedia files